Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Genentech Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 62
» View ky3.com items only
    May 18, 2013 |Story| McClatchy-Tribune
  1. BRIEF: Event features stroke information

    The Record, Stockton, Calif.
    Find out about the signs of stroke from 10 a.m. to 4 p.m. Thursday at the WorkNet Building, 56 S. Lincoln St. The event, sponsored by Stockton nonprofit Healings in Motion and Genentech, is free but requires an RSVP. It will include screenings for...

    Tags: Physical Conditions

  2. May 16, 2013 |Story| Reuters
  3. DEALTALK-Novartis' Vasella exit opens door to Roche stake sale

    Reuters
    * Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...

    Tags: Earnings, Drugs and Medicines, Voting, Swiss Confederation, Patents, Copyrights and Trademarks

  4. May 14, 2013 |Story| Reuters
  5. FDA approves Roche diagnostic for gene mutation in lung cancer

    Reuters
    May 14 (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in...

    Tags: Health Treatments, Medical Procedures and Tests, Chemotherapy, Lung Cancer, Food and Drug Administration

  6. May 12, 2013 |Story| Los Angeles Times
  7. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: U.S. Senate Committee on Appropriations, Health and Medical Professionals, Viral Diseases and Infections, Amgen Inc., Jerry Hill

  8. May 2, 2013 |Story| South Florida Sun-Sentinel
  9. International consortium releases hepatitis C data

    Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...

    Tags: Vertex Pharmaceuticals Incorporated, Food and Drug Administration, Financial Aid, Health and Safety at School, Liver Disease

  10. Apr 29, 2013 |Story| Allentown Morning Call
  11. Passenger on flight out of Philly detained for not flushing toilet

    PHILADELPHIA — A passenger who flew from Philadelphia to San Francisco was detained on arrival by federal agents after a vindictive flight attendant claimed he had not flushed a lavatory toilet, according to a federal suit. The suit, which seeks...

    Tags: Virgin Group, Ltd., FBI

  12. Apr 19, 2013 |Story| Los Angeles Times
  13. Strategies for cutting the cost of prescription drugs

    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it.
    When Maggie Heim had a recurrence of ovarian cancer about a year after her initial treatment, her oncologist suggested that she take what he believed could be a lifesaving drug. There was just one problem: Her insurer wouldn't pay for it. The 59-year-...

    Tags: Prescription Drugs, Herceptin (drug), Insurance, Drugs and Medicines, Employment

  14. Apr 25, 2013 |Story| Los Angeles Times
  15. HIV vaccine trial shut down

    In another major setback for efforts to develop an HIV vaccine, federal researchers have shut down a key clinical trial after an independent panel of safety experts determined that volunteers who got an experimental vaccine appeared to be slightly more...

    Tags: Viral Diseases and Infections, Genetic Engineering, Medical Research, Health Organizations, Pharmaceuticals

  16. Apr 24, 2013 |Story| Chicago Tribune
  17. Boeing, billionaire Penny Pritzker among Obama's donors

    Illinois donors to President Barack Obama’s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records.
    Tribune reporter
    Illinois donors to President Barack Obama’s second inauguration included aviation giant Boeing Co., which contributed $1 million, and billionaire Penny Pritzker, who gave $250,000, according to newly filed records. Pritzker, who is being vetted by...

    Tags: Political Fundraising, Lake Forest, Coca-Cola Co., Entertainment, Robin Kelly

  18. Apr 22, 2013 |Story| Los Angeles Times
  19. Major corporations backed inaugural festivities

    WASHINGTON — President Obama's second inaugural committee raised a little more than $43 million to put on the official festivities surrounding his January swearing-in, backed by major donations from some of the country's biggest corporations,...

    Tags: Political Fundraising, Coca-Cola Co., Labor Legislation, Boeing Co., Lady Gaga

  20. Feb 19, 2013 |Story| Reuters
  21. Almost one-third of chemotherapy used 'off-label'

    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study.
    Reuters
    NEW YORK (Reuters Health) - About one-third of chemotherapies are used to fight cancers that drug regulators never approved them to treat, says a new study. Chemotherapies - drugs that kill rapidly dividing cells - are approved by the Food and Drug...

    Tags: Health Treatments, University of Chicago, Drugs and Medicines, Food and Drug Administration, Medical Research

  22. Mar 29, 2013 |Story| Los Angeles Times
  23. Remove Medicare's straitjacket

    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although raising the age of Medicare eligibility from 65 to 67 appears off the table, at least for now, the budget plan that Rep. Paul D. Ryan (R-Wis.) is proposing would shift a greater share of the program's growing costs to beneficiaries in the years to come.
    Now that the budget "sequester" is in effect, Congress is shifting its attention to entitlement reform. There's simply no way to achieve long-term reductions in federal spending without touching the big health programs, particularly Medicare. Although...

    Tags: New Products, Marketing, Budget Control Act of 2011, Paul Ryan, Fiscal Cliff

 1  2 3 4 5 6Next >
Original site for Genentech Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Genentech Inc. Photos
Some firms seek to make "biosimilar" drugs that would p...
(April 25, 2013)
Bill would regulate ‘biosimilar’ drugs
A sign is displayed in front of the Genentech headquart...
(December 13, 2012)
A sign is displayed in front of the Genentech headquarters July 14, 2008 in South San Francisco, California. This company relied on the popularity of its cancer drug Avastin to boost profits.
Dr. Jeffrey Bloss has joined Astellas US LLC as vice pr...
(November 28, 2012)
Dr. Jeffrey Bloss, vice president of scientific and medical affairs, Astellas US LLC